Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Jon C. Ogg | Feb 28, 2013 at 12:50 PM EST

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or…

Jon C. Ogg | Feb 28, 2013 at 8:25 AM EST

Strange Stock Trends in the Fidelity Contrafund (WFC, JPM, IRE, KO, PEP, BRK-A, BIIB, AMGN, AAPL, GOOG, INTC, MSFT, XOM, CVX)

The Fidelity Contrafund has released its 2012 annual report for its shareholders. While the date is December 31, 2012, and…

Jon C. Ogg | Feb 27, 2013 at 8:30 AM EST

Top Analyst Upgrades and Downgrades (MDRX, BIIB, DRI, FLSR, GOOG, GTI, LNKD, MWE, NOK, OPEN, PKG, PCLN, RSH, VRSN, NCLH)

Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Allscripts Healthcare…

Paul Ausick | Feb 8, 2013 at 4:03 PM EST

24/7 Wall St. Closing Bell — February 8, 2013: Markets Start Higher, Hold on to Gains (DIS, CS, ARMH, BIIB, DFS, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, CCJ, L, NAT, WPP, ZNGA, ONCY, CZR)

U.S. equity markets opened higher this morning boosted by higher-than-expected trade balances in China (more coverage here) and in the…

Jon C. Ogg | Feb 8, 2013 at 10:10 AM EST

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited…

Jon C. Ogg | Feb 8, 2013 at 8:40 AM EST

Top Analyst Upgrades and Downgrades (ALU, NLY, ARMH, BIIB, BX, COF, CS, DFS, IGT, NUAN, KORS, RVBD, VOD, DIS)

Jon OggThese are some of this Friday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Alcatel-Lucent…

Jon C. Ogg | Feb 6, 2013 at 10:05 AM EST

Years Later, MS Drug Ownership Consolidation — M&A Next?

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes “better…

Jon C. Ogg | Jan 29, 2013 at 9:58 AM EST

Top Analyst Upgrades and Downgrades (ANF, AM, AHT, BIIB, BMC, CAT, CLH, DLR, EQIX, IDTI, LGF, RT, STX, SBUX, TSN, VMW)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday.…

Paul Ausick | Jan 28, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than…

Paul Ausick | Jan 28, 2013 at 7:45 AM EST

Biogen Idec Results Mixed

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) reported fourth-quarter and full-year 2012 results before markets opened this morning. For the quarter, the…

Paul Ausick | Jan 25, 2013 at 4:05 PM EST

24/7 Wall St. Closing Bell — January 25, 2013: Markets Open Higher, S&P Closes Over 1,500 (JNS, AMZN, AMGN, AAPL, EBAY, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, CAT, ROP, SIFY, BIIB, NFLX, BFAM, SCSS)

U.S. equity markets opened higher this morning before dipping following the report on new home sales in the U.S. Stocks…

Jon C. Ogg | Jan 15, 2013 at 8:38 AM EST

Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS, DELL, GMCR, INFY, LOGI, LYG, MLNX, NKTR, PDLI, PCYC, REGN, RBS, UAL, LCC, VRTX, VPHM, WFT)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a…

Jon C. Ogg | Jan 9, 2013 at 7:27 AM EST

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

ThinkstockBig biotech had a stellar 2012. In 2013, though, the large biotech companies may be dwarfed in performance by the…

Jon C. Ogg | Jan 3, 2013 at 9:04 AM EST

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) is living up to why we just said it is now an overvalued biotech stock for 2013.…

Jon C. Ogg | Jan 3, 2013 at 8:35 AM EST

Top Analyst Upgrades and Downgrades (ALU, BAC, BIIB, CSCO, C, DMND, GS, JPM, MPEL, PDLI, PCLN, SPWR)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall St. research firms this Thursday.…

1 … 30 31 32 33 34 … 41

Biogen : BIIB

All Biogen Articles

ETF Folly: Biotech ETFs, Nothing but Confusion

Strange Stock Trends in the Fidelity Contrafund (WFC, JPM, IRE, KO, PEP, BRK-A, BIIB, AMGN, AAPL, GOOG, INTC, MSFT, XOM, CVX)

Top Analyst Upgrades and Downgrades (MDRX, BIIB, DRI, FLSR, GOOG, GTI, LNKD, MWE, NOK, OPEN, PKG, PCLN, RSH, VRSN, NCLH)

24/7 Wall St. Closing Bell — February 8, 2013: Markets Start Higher, Hold on to Gains (DIS, CS, ARMH, BIIB, DFS, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, CCJ, L, NAT, WPP, ZNGA, ONCY, CZR)

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Top Analyst Upgrades and Downgrades (ALU, NLY, ARMH, BIIB, BX, COF, CS, DFS, IGT, NUAN, KORS, RVBD, VOD, DIS)

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ANF, AM, AHT, BIIB, BMC, CAT, CLH, DLR, EQIX, IDTI, LGF, RT, STX, SBUX, TSN, VMW)

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

Biogen Idec Results Mixed

24/7 Wall St. Closing Bell — January 25, 2013: Markets Open Higher, S&P Closes Over 1,500 (JNS, AMZN, AMGN, AAPL, EBAY, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, CAT, ROP, SIFY, BIIB, NFLX, BFAM, SCSS)

Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS, DELL, GMCR, INFY, LOGI, LYG, MLNX, NKTR, PDLI, PCYC, REGN, RBS, UAL, LCC, VRTX, VPHM, WFT)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Top Analyst Upgrades and Downgrades (ALU, BAC, BIIB, CSCO, C, DMND, GS, JPM, MPEL, PDLI, PCLN, SPWR)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Biogen : BIIB

All Biogen Articles

ETF Folly: Biotech ETFs, Nothing but Confusion

Strange Stock Trends in the Fidelity Contrafund (WFC, JPM, IRE, KO, PEP, BRK-A, BIIB, AMGN, AAPL, GOOG, INTC, MSFT, XOM, CVX)

Top Analyst Upgrades and Downgrades (MDRX, BIIB, DRI, FLSR, GOOG, GTI, LNKD, MWE, NOK, OPEN, PKG, PCLN, RSH, VRSN, NCLH)

24/7 Wall St. Closing Bell — February 8, 2013: Markets Start Higher, Hold on to Gains (DIS, CS, ARMH, BIIB, DFS, ATVI, CSTR, LNKD, RVBD, SPWR, AOL, APO, MCO, CCJ, L, NAT, WPP, ZNGA, ONCY, CZR)

﻿﻿JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Top Analyst Upgrades and Downgrades (ALU, NLY, ARMH, BIIB, BX, COF, CS, DFS, IGT, NUAN, KORS, RVBD, VOD, DIS)

Years Later, MS Drug Ownership Consolidation — M&A Next?

Top Analyst Upgrades and Downgrades (ANF, AM, AHT, BIIB, BMC, CAT, CLH, DLR, EQIX, IDTI, LGF, RT, STX, SBUX, TSN, VMW)

24/7 Wall St. Closing Bell — January 28, 2013: Markets Open Mixed, Close Nearly Flat (AKS, HEP, NWSA, FB, BBY, CAT, ROP, SIFY, BIIB, YHOO, STX, VMW, STLD, BSX, DHI, F, BTU, PFE, VLO, KERX, JOSB, HLF)

Biogen Idec Results Mixed

24/7 Wall St. Closing Bell — January 25, 2013: Markets Open Higher, S&P Closes Over 1,500 (JNS, AMZN, AMGN, AAPL, EBAY, T, JNPR, MSFT, SBUX, HAL, HON, KMB, WY, CAT, ROP, SIFY, BIIB, NFLX, BFAM, SCSS)

Top Analyst Upgrades and Downgrades (AFL, AXP, AINV, ARMH, BIIB, CELG, CS, DELL, GMCR, INFY, LOGI, LYG, MLNX, NKTR, PDLI, PCYC, REGN, RBS, UAL, LCC, VRTX, VPHM, WFT)

The Big Biotech Winners and Losers for 2013 (AMGN, BIIB, CELG, GILD, ALXN, ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Lou Gehrig’s Disease Drug Failure Crushes Biogen Idec

Top Analyst Upgrades and Downgrades (ALU, BAC, BIIB, CSCO, C, DMND, GS, JPM, MPEL, PDLI, PCLN, SPWR)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)